Halozyme Therapeutics (HALO) – Hot New Coverage
-
Wells Fargo Starts Halozyme Therapeutics (HALO) at Equal Weight, 'Seven Reasons to Own HALO'
-
UPDATE: SVB Leerink Assumes Halozyme Therapeutics (HALO) at Outperform, 'Durability Underappreciated for This Partner of Choice'
-
-
-
-
Back to HALO Stock Lookup